Key Metrics
CiteScore 

3.7
H-Index 

44
Impact Factor 

< 5
SJR 

Q1Rheumatology

SNIP 

1.17
Recommended pre-submission checks
Powered by 

Topics Covered on Therapeutic Advances in Musculoskeletal Disease
Therapeutic Advances in Musculoskeletal Disease Journal Specifications
| Overview | |
| Publisher | SAGE PUBLICATIONS LTD |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2300 |
| Publication Time | 18 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2009 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in Therapeutic Advances in Musculoskeletal Disease ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Therapeutic Advances in Musculoskeletal Disease
Therapeutic management of axial spondyloarthritis: summary of 2024 update of the Spanish clinical practice guideline (ESPOGUIA)
- 1 Aug 2026
- Therapeutic Advances in Musculoskeletal Disease
Clinical spectrum and outcomes of mononeuritis multiplex in rheumatic diseases: evidence from a nationwide multicenter study
- 1 Aug 2026
- Therapeutic Advances in Musculoskeletal Disease
Recurrent uveitis unveiling axial spondyloarthritis: is inflammatory back pain always the main road to diagnosis? A monocentric cohort
- 1 Aug 2026
- Therapeutic Advances in Musculoskeletal Disease
MCCs in adults with autoimmune and inflammatory rheumatic diseases: evidence to date and future directions
- 25 Jul 2026
- Therapeutic Advances in Musculoskeletal Disease
Longitudinal osteoporosis therapy: treat-to-target and sequential strategies\u2014a narrative review
- 21 Jul 2026
- Therapeutic Advances in Musculoskeletal Disease
Cardiometabolic disease and risk of total knee arthroplasty among patients with knee osteoarthritis receiving intra-articular hyaluronic acid: a real-world cohort study
- 20 Jul 2026
- Therapeutic Advances in Musculoskeletal Disease
Therapeutic management of axial spondyloarthritis: summary of 2024 update of the Spanish clinical practice guideline (ESPOGUIA)
- 1 Aug 2026
- Therapeutic Advances in Musculoskeletal Disease
Clinical spectrum and outcomes of mononeuritis multiplex in rheumatic diseases: evidence from a nationwide multicenter study
- 1 Aug 2026
- Therapeutic Advances in Musculoskeletal Disease
Recurrent uveitis unveiling axial spondyloarthritis: is inflammatory back pain always the main road to diagnosis? A monocentric cohort
- 1 Aug 2026
- Therapeutic Advances in Musculoskeletal Disease
MCCs in adults with autoimmune and inflammatory rheumatic diseases: evidence to date and future directions
- 25 Jul 2026
- Therapeutic Advances in Musculoskeletal Disease
Longitudinal osteoporosis therapy: treat-to-target and sequential strategies\u2014a narrative review
- 21 Jul 2026
- Therapeutic Advances in Musculoskeletal Disease
Cardiometabolic disease and risk of total knee arthroplasty among patients with knee osteoarthritis receiving intra-articular hyaluronic acid: a real-world cohort study
- 20 Jul 2026
- Therapeutic Advances in Musculoskeletal Disease